MAPP BIOPHARMACEUTICAL, INC.

Federal contract awards won by MAPP BIOPHARMACEUTICAL, INC. (UEI M9V9QTHR1H28), 2016–2025 — public record from USAspending.

Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

10
awards
$363,248,449
total value
2
agencies

Agencies buying from MAPP BIOPHARMACEUTICAL, INC.

Awards

MATERIAL REQUIREMENT FOR THE DELIVERY OF ANTIBODY AND ANTIGEN SUPPLY.
Department of Defense · $2,000,000 · Jun 1, 2025
DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS
Department of Health and Human Services · $3,004,498 · Mar 20, 2024
PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES
Department of Health and Human Services · $134,839,789 · Sep 30, 2022
BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2
Department of Defense · $480,000 · Sep 30, 2021
DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE
Department of Health and Human Services · $16,303,707 · Sep 30, 2020
STTR PHASE II
Department of Defense · $1,499,004 · Jul 28, 2020
IGF::OT::IGF
Department of Health and Human Services · $55,836,771 · Sep 25, 2018
IGF::OT::IGF
Department of Health and Human Services · $7,486,451 · Sep 13, 2017
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
Department of Health and Human Services · $30,920,845 · Jun 27, 2016

Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.

Search open bids